ARTLVSNRSN• 12 Months (Normalized)
ARTL vs NRSN (Artelo Biosciences Inc. vs NeuroSense Therapeutics Ltd.)
Showing Closing Date Range from Sep 30, 2025 to Sep 30, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
ARTL Performance $4.54
+%
Artelo Biosciences Inc.
Normalized Baseline0.00%
NRSN Performance $4.78
+282.4%
NeuroSense Therapeutics Ltd.
Normalized Baseline0.00%
Alpha Spread Margin NRSN LEADS
-282.4 pts
NRSN outperforming by 282.40 percentage points
ARTLNRSN
Spread Trajectory12 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
ARTL NRSN
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(251 dates)
| Date | ARTL Price | ARTL Gain (%) | NRSN Price | NRSN Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 29, 2026 | $- | $4.78 | +282.40% | - | |
| Sep 28, 2026 | $- | $5.10 | +308.00% | - | |
| Sep 25, 2026 | $4.54 | -96.34% | $6.95 | +456.00% | -552.34% |
| Sep 24, 2026 | $5.17 | -95.83% | $7.40 | +492.00% | -587.83% |
| Sep 23, 2026 | $7.31 | -94.10% | $7.40 | +492.00% | -586.10% |
| Sep 22, 2026 | $4.15 | -96.65% | $7.18 | +474.40% | -571.05% |
| Sep 21, 2026 | $4.10 | -96.69% | $6.62 | +429.60% | -526.29% |
| Sep 18, 2026 | $3.94 | -96.82% | $6.35 | +408.00% | -504.82% |
| Sep 17, 2026 | $3.97 | -96.80% | $6.72 | +437.60% | -534.40% |
| Sep 16, 2026 | $3.75 | -96.97% | $6.49 | +419.20% | -516.17% |
| Sep 15, 2026 | $5.34 | -95.69% | $7.03 | +462.40% | -558.09% |
| Sep 14, 2026 | $4.87 | -96.07% | $6.90 | +452.00% | -548.07% |
| Sep 11, 2026 | $5.43 | -95.62% | $0.35 | -72.24% | -23.38% |
| Sep 10, 2026 | $5.63 | -95.46% | $0.33 | -73.44% | -22.02% |
| Sep 09, 2026 | $5.98 | -95.17% | $0.40 | -67.92% | -27.25% |
Page 1 of 17